Omnicell, Inc. Aktie News

6,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).

Omnicell, Inc. (OMCL) Discusses Launch of Titan XT Enterprise Platform and Its Impact on Pharmacy Operations Transcript

FORT WORTH, Texas--(BUSINESS WIRE)--Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies.

It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability.

Omnicell, Inc. ( OMCL ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Kathleen Nemeth - Senior Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman, President & CEO H. Radford - Executive VP & CFO Conference Call Participants Jessica Tassan - Piper Sandler & Co., Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Div...